La reunión anual de la American Society of Clinical Oncology (ASCO) se lleva a cabo del 3 al 7 de junio, y estas son algunas de las investigaciones destacadas que se presentarán hoy. Los temas incluyen avances en el tratamiento del cáncer de mama metastásico HER2 bajo, el cáncer colorrectal metastásico con RAS de tipo wild-type, el sarcoma de Ewing recidivante y resistente al tratamiento y el mieloma múltiple de diagnóstico reciente. Read More
Blog
June 5, 2022 Leslie Fannon Zhang, ASCO staff
June 5, 2022 Leslie Fannon Zhang, ASCO staff
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include advances in treating HER2-low metastatic breast cancer, RAS wild-type metastatic colorectal cancer, recurrent and refractory Ewing sarcoma, and newly diagnosed multiple myeloma. Read More
June 4, 2022 Brielle Gregory Collins, ASCO staff
La reunión anual de la American Society of Clinical Oncology (Sociedad Estadounidense de Oncología Clínica) tendrá lugar del 3 al 7 de junio y estas son algunas de las investigaciones destacadas que se presentarán. Entre los temas se incluyen la terapia dirigida contra el cáncer de mama avanzado que es RH positivo y HER2 negativo y el uso de biopsia líquida para guiar las decisiones de tratamiento posquirúrgico del cáncer de colon en estadio II. Read More
June 4, 2022 Brielle Gregory Collins, ASCO staff
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include targeted therapy for advanced hormone receptor-positive, HER2-negative breast cancer and using liquid biopsy to guide post-surgery treatment decisions for stage II colon cancer. Read More
June 3, 2022 Greg Guthrie, ASCO staff
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Today’s studies explore adding nimotuzumab to chemotherapy to treat KRAS wild-type pancreatic cancer and adding ibrutinib to standard care for older adults with mantle cell lymphoma. Read More